Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial - Jonas Sundén-Cullberg; Puran Chen; Henrike Häbel; Paul Skorup; Helena Janols; Johan Rasmuson; Katarina Niward; Åse Östholm Balkhed; Katerina Chatzidionysiou; Hilmir Asgeirsson; Ola Blennow; Åsa Parke; et al. (PLoS ONE, 2023)